Stay updated on T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Sign up to get notified when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.

Latest updates to the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page
- Check5 days agoChange DetectedA new revision label v3.5.4 was added, replacing v3.5.3 to indicate an updated version of the page content.SummaryDifference0.0%

- Check12 days agoChange DetectedA Taiwan site listing was updated to change the location name from Taoyuan District to Taoyuan, indicating a naming correction in the study's locations. The underlying postal code 333 remains associated with the site.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe site now displays the Gurgaon, India research location name without the diacritic and updates the page’s revision/build version indicator.SummaryDifference0.0%

- Check34 days agoChange DetectedThe page revision label updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check41 days agoChange DetectedPadova, Italy, 35128 was added as a trial location and Padua, Italy, 35128 was removed. This aligns the location listing with the local naming convention to ensure accurate site identification.SummaryDifference0.0%

- Check48 days agoChange DetectedPublications section updated: added the 2026 NEJM article 'Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer' and removed the 2025 online-ahead-of-print citation.SummaryDifference0.0%

Stay in the know with updates to T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd ± Pertuzumab vs Taxane, Trastuzumab, Pertuzumab Clinical Trial page.